Page last updated: 2024-09-04

13,14-dihydroprostaglandin e1 and 5-hydroxydecanoate

13,14-dihydroprostaglandin e1 has been researched along with 5-hydroxydecanoate in 1 studies

Compound Research Comparison

Studies
(13,14-dihydroprostaglandin e1)
Trials
(13,14-dihydroprostaglandin e1)
Recent Studies (post-2010)
(13,14-dihydroprostaglandin e1)
Studies
(5-hydroxydecanoate)
Trials
(5-hydroxydecanoate)
Recent Studies (post-2010) (5-hydroxydecanoate)
2723431093

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hide, EJ; Ney, P; Piper, J; Thiemermann, C; Vane, JR1

Other Studies

1 other study(ies) available for 13,14-dihydroprostaglandin e1 and 5-hydroxydecanoate

ArticleYear
Reduction by prostaglandin E1 or prostaglandin E0 of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels.
    British journal of pharmacology, 1995, Volume: 116, Issue:5

    Topics: Adenosine Triphosphate; Alprostadil; Animals; Anti-Arrhythmia Agents; Biotransformation; Blood Pressure; Decanoic Acids; Electrocardiography; Glyburide; Heart Rate; Hydroxy Acids; Hypoglycemic Agents; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Potassium Channels; Rabbits; Vasodilator Agents

1995